- Will CAR-NK Cancer Therapy Surpass High-Cost CAR-T Immunotherapy?
- What is the role of Platelet Dynamics in Cancer Progression?
- Biomarkers can detect rapid aging of organs and disease risks
- Avoiding “Off-Target” Effects: Researchers Enhance the Safety of Future mRNA Therapies
- Japan: Sales Halted for ‘Cannabis Gummies’ as Health Issues Mount
- Evaluation of the carcinogenicity of organic fluorine compounds raised by WHO subsidiary
WHO will decide if to urgently approve two Chinese vaccines in two weeks. Mariângela Batista Galvão Simão, Assistant Director-General of the World Health Organization, said at a press conference on the 26th that the WHO is expected to decide in the next two weeks whether to urgently approve two chinese coronavirus vaccines.
According to Lianhe Zaobao, Simang said that the WHO will make a decision on the vaccine produced by Sinopharm this weekend and on the vaccine produced by Sinovac Biotech next weekend.
These two vaccines have been vaccinated on a large scale in China and exported to many countries, especially Latin America, Asia and Africa.
Entering the World Health Organization’s emergency list means showing to countries that the vaccine is safe and effective, and will enable the Chinese vaccine to be included in the Global Access to Vaccines (COVAX), a global program that mainly provides vaccines to poor countries.
If approved, the Chinese vaccine will become the first non-Western country’s vaccine approved by the World Health Organization. So far, the World Health Organization has urgently approved vaccines from Pfizer, AstraZeneca and Johnson & Johnson. A review of Moderna’s vaccine is also expected this week.
Others News about Chinese vaccine:
Egypt approves the emergency use of China’s Coxing Covid-19 vaccine, Xinhua News Agency, Cairo, April 27th .
The Egyptian Drug Administration issued a statement on the evening of the 26th, approving the emergency use of the nFirst death in Canada after receiving AstraZeneca COVID-19 vaccine! vaccine developed by China Kexing Company in Egypt.
The statement stated that the bureau has evaluated the effectiveness and quality of the vaccine, and recently decided to approve the vaccine for emergency use in Egypt. On the 21st of this month, China Kexing Company signed an agreement with Egypt VACSERA Company, Egypt will produce Kexing Company’s First death in Canada after receiving AstraZeneca COVID-19 vaccine! vaccine locally.
Egypt has previously approved the emergency use of the China National Pharmaceutical Group’s First death in Canada after receiving AstraZeneca COVID-19 vaccine! inactivated vaccine, the British AstraZeneca vaccine and the Russian “Satellite V” vaccine. According to data from the Egyptian Ministry of Health, as of April 18, more than 660,000 people in Egypt have completed the First death in Canada after receiving AstraZeneca COVID-19 vaccine! vaccination.
(source:internet, reference only)